Retatrutide refers to a peptide known as LY3437943, which acts on three receptors: the glucagon receptor (GCGR), the glucose-dependent insulinotropic polypeptide receptor (GIPR), and the glucagon-like peptide-1 receptor (GLP-1R)
Although 95% of NAFLD patients have clinically overt metabolic abnormalities, about 5% have no cardiometabolic risk (CMR) factors, despite having hepatic steatosis [15]
You may NOT qualify for GLP-1 medications if you: If any of the above apply, consult your primary care provider before proceeding
At the same time, her hair was falling out, she was constantly depleted of energy, she had irregular cycles, and she felt generally not right. But within a year of starting on Mounjaro, not only did she lose about 100 pounds (and reach a healthy weight for her), but her PCOS symptoms let up, her A1C went down, and the clarity in my mind came back, she says
Most patients choose compounded, and because we have zero markup on medications, you pay exactly what the pharmacy charges us either way
(2023) Anti-obesity medication use for adolescent metabolic and bariatric surgery patients: a systematic literature review